Literature DB >> 18802418

The next steps for genomic medicine: challenges and opportunities for the developing world.

Billie-Jo Hardy1, Béatrice Séguin, Federico Goodsaid, Gerardo Jimenez-Sanchez, Peter A Singer, Abdallah S Daar.   

Abstract

This is a historical moment on the path to genomic medicine - the point at which theory is about to be translated into practice. We have previously described human genome variation studies taking place in Mexico, India, Thailand, and South Africa. Such investments into science and technology will enable these countries to embark on the path to the medical and health applications of genomics, and to benefit economically. Here we provide a perspective on the challenges and opportunities facing these and other countries in the developing world as they begin to harness genomics for the benefit of their populations.

Entities:  

Mesh:

Year:  2008        PMID: 18802418     DOI: 10.1038/nrg2444

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  16 in total

1.  Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa.

Authors:  Morne Du Plessis; Brendon Pearce; Clifford Jacobs; Nisreen Hoosain; Mongi Benjeddou
Journal:  Mol Biol Rep       Date:  2014-11-15       Impact factor: 2.316

Review 2.  Can pharmacogenomics improve malaria drug policy?

Authors:  Mary W Roederer; Howard McLeod; Jonathan J Juliano
Journal:  Bull World Health Organ       Date:  2011-09-01       Impact factor: 9.408

3.  Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico.

Authors:  Irma Silva-Zolezzi; Alfredo Hidalgo-Miranda; Jesus Estrada-Gil; Juan Carlos Fernandez-Lopez; Laura Uribe-Figueroa; Alejandra Contreras; Eros Balam-Ortiz; Laura del Bosque-Plata; David Velazquez-Fernandez; Cesar Lara; Rodrigo Goya; Enrique Hernandez-Lemus; Carlos Davila; Eduardo Barrientos; Santiago March; Gerardo Jimenez-Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

4.  Roadmap for Establishing Large-Scale Genomic Medicine Initiatives in Low- and Middle-Income Countries.

Authors:  George P Patrinos; Emmanouil Pasparakis; Erasmia Koiliari; Alexandre C Pereira; Tábita Hünemeier; Lygia V Pereira; Christina Mitropoulou
Journal:  Am J Hum Genet       Date:  2020-10-01       Impact factor: 11.025

Review 5.  Pediatric clinical drug trials in low-income countries: key ethical issues.

Authors:  S M MacLeod; D C Knoppert; M Stanton-Jean; D Avard
Journal:  Paediatr Drugs       Date:  2015-02       Impact factor: 3.022

Review 6.  From big data analysis to personalized medicine for all: challenges and opportunities.

Authors:  Akram Alyass; Michelle Turcotte; David Meyre
Journal:  BMC Med Genomics       Date:  2015-06-27       Impact factor: 3.063

7.  Pharmacogenomics in osteoporosis: Steps toward personalized medicine.

Authors:  Robert Greene; Shaymaa S Mousa; Mohamed Ardawi; Mohamed Qari; Shaker A Mousa
Journal:  Pharmgenomics Pers Med       Date:  2009-09-10

8.  Filling kinetic gaps: dynamic modeling of metabolism where detailed kinetic information is lacking.

Authors:  Osbaldo Resendis-Antonio
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

9.  Biomedical research, a tool to address the health issues that affect African populations.

Authors:  Emmanuel Peprah; Ambroise Wonkam
Journal:  Global Health       Date:  2013-10-21       Impact factor: 4.185

10.  Family Experiences with Care for Children with Inherited Metabolic Diseases in Canada: A Cross-Sectional Survey.

Authors:  Andrea J Chow; Michael Pugliese; Laure A Tessier; Pranesh Chakraborty; Ryan Iverson; Doug Coyle; Jonathan B Kronick; Kumanan Wilson; Robin Hayeems; Walla Al-Hertani; Michal Inbar-Feigenberg; Shailly Jain-Ghai; Anne-Marie Laberge; Julian Little; John J Mitchell; Chitra Prasad; Komudi Siriwardena; Rebecca Sparkes; Kathy N Speechley; Sylvia Stockler; Yannis Trakadis; Jagdeep S Walia; Brenda J Wilson; Beth K Potter
Journal:  Patient       Date:  2021-07-20       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.